ISRCTN25782645已完成不适用
A randomised, double-blind, negatively-controlled study to determine whether the use of creams or ointments could alter the sensitivity of the skin to ultraviolet light during photo-therapy with narrow band UVB
Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)0 个研究点目标入组 20 人开始时间: 2004年9月30日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Not provided at time of registration
排除标准
- •Not provided at time of registration
研究者
相似试验
尚未招募
4 期
A multi-center clinical trial to evaluate the efficacy and safety of Kangbingdu Granulesin the treatment of influenzainfluenzaITMCTR1900002747China-Japan Friendship Hospital
已完成
不适用
A randomised, prospective, double-blind controlled study evaluating the effectiveness of spinal endoscopy with adhesiolysis for the treatment of chronic low back paiISRCTN16558617Institutional Review Board of Ambulatory Surgery Center (USA)83
进行中（未招募）
不适用
A controlled, randomised, double-blind, double-dummy, parallel-group, phase III, multicenter study to evaluate efficacy and safety of the oral direct thrombin inhibitor AZD0837 compared to warfarin for the prevention of stroke and systemic embolic events (SEE) in patients with atrial fibrillation (ASSURE-AF) - ASSURE-AFthe prevention of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (AF)MedDRA version: 9.1Level: LLTClassification code 10003658Term: Atrial fibrillationEUCTR2008-003698-42-DKAstraZeneca AB14,600
进行中（未招募）
不适用
A controlled, randomised, double-blind, double-dummy, parallel-group, phase III, multicenter study to evaluate efficacy and safety of the oral direct thrombin inhibitor AZD0837 compared to warfarin for the prevention of stroke and systemic embolic events (SEE) in patients with atrial fibrillation (ASSURE-AF) - ASSURE-AFEUCTR2008-003698-42-SEAstraZeneca AB14,600
进行中（未招募）
不适用
A controlled, randomised, double-blind, double-dummy, parallel-group, phase III, multicenter study to evaluate efficacy and safety of the oral direct thrombin inhibitor AZD0837 compared to warfarin for the prevention of stroke and systemic embolic events (SEE) in patients with atrial fibrillation (ASSURE-AF) - ASSURE-AFEUCTR2008-003698-42-BGAstraZeneca AB14,600